Under construction – not a live service
Sign in
Not yet taking people in ThailandNo phase

Headache and hormone use among transgender adults in Thailand

Studies how common headache and migraine are in transgender adults in Thailand.

Plain-language title generated from the registry record
Registry title: Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study

Key facts

Where
Bangkok, ThailandSee the site

Where in Thailand

  • Location Back to Contacts and Locations On this page, enter a location where the study is taking place.Bangkok, ThailandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chulalongkorn University
Trial code
NCT07817446
Record updated
14 September 2026
Original description
The goal of this observational study is to learn how common headache and migraine are and to describe headache patterns among transgender adults in Thailand. The main questions it aims to answer are:Read full original descriptionShow less

Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study

The goal of this observational study is to learn how common headache and migraine are and to describe headache patterns among transgender adults in Thailand. The main questions it aims to answer are:

* How common are headache and migraine among transgender adults in Thailand? * What headache patterns and levels of headache-related disability do participants report? * Are gender-affirming hormone therapy, gender-affirming surgery, or HIV pre-exposure prophylaxis (PrEP) use related to headache or migraine?

About 500 transgender adults aged 18 years or older who currently attend or previously attended the Tangerine Clinic in Bangkok, Thailand, will take part.

Participants will:

* Provide consent online * Complete an online questionnaire about their general health and headache symptoms * Answer questions about gender-affirming hormone therapy, gender-affirming surgery, and PrEP use * Complete questionnaires that screen for migraine and measure how headaches affect daily activities

This study will not assign any treatment or change the participants' usual medical care.

Inclusion: Age 18 years or older; Self-identifies as transgender; Currently attends or has previously attended the Tangerine Clinic in Bangkok, Thailand; Able to understand the study information and provide electronic informed consent; Able to complete the online study questionnaire.

Exclusion: Alcohol or drug use, or a medical condition that, in the investigator's judgment, could interfere with completion of the study procedures or the ability to provide informed consent; A medical condition known to cause a secondary headache disorder unrelated to migraine, such as head trauma, a structural brain lesion, or an infection.

ClinicalTrials.gov NCT07817446